お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
965389

ナノロボティクス市場-成長、動向、予測(2020年~2025年)

Nanorobotics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
ナノロボティクス市場-成長、動向、予測(2020年~2025年)
出版日: 2021年01月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ナノロボットとは、ナノロボットのエンジニアリング、設計、構築を含むナノテクノロジーを指します。ナノロボットは、ナノスケールまたは分子成分で構成される1~100ナノメートルのサイズのデバイスです。

  • ナノボットは、細胞レベルで診断または治療を行うために患者に注入されます。ナノロボットによる治療には、分子レベルまたは亜分子レベルでの構造と組成の変化が含まれる場合があります。ナノロボットのさまざまな応用分野は、ナノスケールの寸法で材料とデバイスの独自の特性を活用しています。
  • 2019年には、何十ものスタートアップがこの新たな新しい分野に参入しようとしました。そのうちの1つはプラハに拠点を置くPumeramで、すでに1,150万ユーロを調達して、皮膚や口腔の病気から生殖能力の問題に至るまでの病気の治療に役立つロケット、回転楕円体、さらにはねじ形のナノボットを開発しています。ガンを殺すナノボットは、すでにマウスでテストされています。
  • グーグルが、大手製薬大手のグラクソ・スミスクラインと提携していることは、将来のナノロボティクスの重要性を示しています。
  • 2020年には、世界中の研究者が、人間に対してさまざまな手術を行うことができる熟練したナノボットを開発しています。それらはプログラムされ、外部磁場で誘導されます。ナノボットは、針で眼科手術を行い、動脈の閉塞に栓抜きを開けて閉塞した動脈を取り除き、生検を収集することができます。

当レポートでは、ナノロボティクス市場を調査し、市場概要、市場の成長要因および阻害要因の分析、タイプ別・用途別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場の推進力
    • 政府や大学別テクノロジーへの投資の増加
    • 高度な医療に対する需要の高まり
  • 市場の抑制要因
    • 高い製造および開発コスト
  • ポーターのファイブフォース分析
  • テクノロジースナップショット
  • COVID-19の業界への影響の評価

第5章 市場セグメンテーション

  • 製造の種類別
    • バイオチップ
    • Nubots
    • バクテリアナノボット
    • 3Dプリント
    • その他のタイプ
  • 用途別
    • 医療画像処理
    • 情報ストレージ
    • ドラッグデリバリー
    • 健康センサーとレプリケーター
    • その他の用途
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第6章 競合情勢

  • 企業プロファイル
    • Ginkgo Bioworks Inc
    • Imina Technologies SA
    • Oxford Instruments
    • EV Group
    • Thermo Fisher Scientific Inc.
    • Zymergen Inc.
    • Illumina Inc.
    • Nanoics Imaging Limited
    • Synthace Limited
    • Toronto Nano Instrumentation Inc.

第7章 投資分析

第8章 市場機会と動向

目次
Product Code: 69593

The nanorobotics market registered a CAGR of 10% during the forcasted period (2021-2026). Nanorobotics refers to nanotechnology that involves engineering, designing, and building of nanorobots. Nanorobots are devices ranging in size from 1 to 100 nanometers that are composed of nanoscale or molecular components.

  • Nanobots are injected into the patient to perform diagnosis or treatment on a cellular level, and the diagnosis or treatments involve the nanoscale, molecular, or atomic level. Treatments with nanorobots may include alterations in the structure and composition at the molecular or submolecular level. The various areas of applications of nanorobots leverage the unique properties of materials and devices in the nanoscale dimensions.
  • In 2019, dozens of startups looked to get in on this emerging new field. One of those is Pumeram, which is based in Prague and has already raised EUR 11.5 million to develop rocket, spheroid, and even screw-shaped nanobots that will help treat diseases ranging from skin and oral ailments to fertility problems. The startup's cancer-killing nanobots have already been successfully tested on mice.
  • The tech giant, Google, partnered with the big pharma giant GlaxoSmithKline to form its nanobot powerhouse shows the significance of nanorobotics in the future. Eligo, a startup founded in France, raised USD 27.4 million till mid-2019 to put protein-based nanobots in the bowels and is now focused on moving different clinical programs into humans.
  • In 2020, researchers around the world are developing skilled nanobots that can perform a wide range of surgeries on humans. They will be programmed and guided with external magnetic fields. Nanobots can perform eye surgeries with needles, clear blocked arteries by drilling a corkscrew through arterial blockages and collect biopsies.
  • Since the coronavirus outbreak began in late 2019, researchers are racing to learn more about SARS-CoV-2, which is a strain from a family of viruses known as coronavirus for their crown-like shape. Various researchers are proposing the idea of using nanoparticles that are a similar size to the virus behind COVID-19 that could attach to SARS-CoV-2 viruses, disrupting their structure with a combination of infrared light treatment and this expected to boost the market if the practice succeeds.

Key Market Trends

Drug Delivery Application is Expected to Witness Significant Growth Rate

  • Nanobots are an emerging field, showing great potential as a form of drug delivery. The ability to target difficult-to-reach areas of the body while carrying medicinal compounds is highly sought after as a biomedical application. Although there are still advances to be made in the field, previous research indicates that they will be vital in combatting hard-to-treat diseases. A significant challenge for most researchers, however, is ensuring that their concepts will be successful on the nanoscale.
  • In the last few years, research into engineered nanobots that can navigate through the body to deliver drugs with precision has intensified. In December 2019, Researchers from IIT Guwahati had come up with nanobots synthesized from tea extracts, named 'teabots,' which can serve as biocompatible drug-delivery agents.
  • In September 2019, Michigan State University scientists invented a new way to monitor chemotherapy concentrations, where they created a process based around magnetic particle imaging that employs superparamagnetic nanoparticles as the contrast agent and the sole signal source to control drug release in the body at the site of the tumor. Nanobots are used to target harder-to-reach portions of cancerous tumors, which will be a potential increase in the chances of successful chemotherapy as well.
  • In 2019, DNA nanorobots were developed, which consists of a track and a walker system to reach the target location and contained a self-assembly system consisting of DNA strands with the ability to produce a functional molecule. All the concepts and designs proposed by the researchers for nanorobots in the drug delivery application are successful and promising. Yet, improvements are needed before being deployed on a larger scale.

North America is Expected to Hold a Major Share

  • North America is expected to hold a major market share over the forecast period. One of the driving factors for the region's growth is the considerable growth in the backing of nanorobotics from the Defense Advanced Research Projects Agency (DARPA) and the National Science Foundation (NSF). The growth of adoption in nanotechnology, coupled with high expenditure on healthcare, is expected to create a positive impact on the market in the region.
  • The United States has one of the highest costs of healthcare in the world. In 2018, the United States spent about USD 3.6 trillion on healthcare, which averages to about USD 11,000 per person. The Centers for Medicare and Medicaid Services (CMS) project that by 2028, such costs will climb to USD 6.2 trillion, or about USD 18,000 per person, and will represent about 20 percent of GDP. As most of the applications of nanorobotics are related to health care, the region is expected to witness the increase in the adoption of the technology in such related applications.
  • However, the most direct impact the coronavirus pandemic will have on U.S. health care spending is through testing and treatment of COVID-19. The University of Washington Institute for Health Metrics and Evaluation (IHME) model suggests the outbreak is reaching its peak in the U.S. and is bound to put a severe strain on the government in terms of spending to tackle the virus. Although researchers are contemplating the idea of using nanoparticles to combat the virus, the idea is still in a nascent stage, and the research activities of nanorobotics backed by the government may witness significant delays.

Competitive Landscape

The nanorobotics market is highly consolidated and consists of a few significant players. In terms of market share, few of the major players currently dominate the market as the technology is still in a developmental phase. The companies and researchers are yet to deploy the applications of nanorobotics commercially. However, the growth of certain start-ups is expected over the forecast period.

  • June 2019 - EV Group launched a fully integrated track system that combines cleaning, resist coating, and baking pre-processing steps with the company's proprietary SmartNIL wafer-level nanoimprint lithography process in a single platform for wafers up to 300 millimeters in diameter. It supports the production of a variety of devices and applications, including optical devices for augmented/virtual reality (AR/VR) headsets, 3D sensors, bio-medical devices, nanophotonics, and plasmonics.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Investment in Technology by Governments and Universities
    • 4.2.2 Growing Demand for Advanced Medical Treatments
  • 4.3 Market Restraints
    • 4.3.1 High Manufacturing and Development Costs
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry
  • 4.5 Technology Snapshot
  • 4.6 Assessment of Impact of COVID-19 on the Industry

5 MARKET SEGMENTATION

  • 5.1 Type of Manufacuturing
    • 5.1.1 Biochips
    • 5.1.2 Nubots
    • 5.1.3 Bacteria-based Nanobots
    • 5.1.4 3D Printing
    • 5.1.5 Other Types
  • 5.2 Application
    • 5.2.1 Medical Imaging
    • 5.2.2 Information Storage
    • 5.2.3 Drug Delivery
    • 5.2.4 Health Sensors and Replicators
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 Unites States
      • 5.3.1.2 Canada
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 India
      • 5.3.3.2 China
      • 5.3.3.3 Japan
      • 5.3.3.4 Rest of Asia-Pacific
    • 5.3.4 Rest of the World
      • 5.3.4.1 Latin America
      • 5.3.4.2 Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ginkgo Bioworks Inc
    • 6.1.2 Imina Technologies SA
    • 6.1.3 Oxford Instruments
    • 6.1.4 EV Group
    • 6.1.5 Thermo Fisher Scientific Inc.
    • 6.1.6 Zymergen Inc.
    • 6.1.7 Illumina Inc.
    • 6.1.8 Nanoics Imaging Limited
    • 6.1.9 Synthace Limited
    • 6.1.10 Toronto Nano Instrumentation Inc.

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.